The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis
Keywords: ATP; P2X7 receptor; Parkinson's disease; Synaptotoxicity; Neuroprotection; Microglia; Astrocytes; DopamineBBG, Brilliant Blue G; CD11b, cluster of differentiation molecule 11B; DA, dopamine; DAT, dopamine transporters; DOPAC, 3,4 dihydroxyphenylacetic aci